latest news on tirzepatide Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg Breaking News: OFA Challenges FDA

Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events

doi:10.1016/j.molmet.2015.03.005 Goldstone AP, Thomas EL, Brynes AE, Castroman G, Edwards R, Ghatei MA, et al

Irritable bowel syndrome affects approximately 1015% of the global population, and many of those individuals also struggle with weight management

And more often than not, it has nothing to do with your willpower and everything to do with metabolism, hormones, and lifestyle

Seek medical advice if you are unable to keep fluids down or notice a significant reduction in urine output